Atlas Trials

A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disorder

Clinical trial NCT03854409 · COMPLETED

Trial details

NCT number
NCT03854409
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
SchizophreniaBipolar I Disorder
Start date
2019-01-31
Primary completion
2019-04-05
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.